Select Publications
Conference Papers
, 2015, 'Survival benefits of multi-disciplinary team care in hepatocellular carcinoma at Liverpool Hospital, New South Wales, 2003–2013', in Journal of Gastroenterology and Hepatology, pp. 95 - 116, http://dx.doi.org/10.1111/jgh.13093
, 2014, 'The landscape of pregant women with hepatitis B in a single centre', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1010A - 1010A, presented at
, 2014, 'Treatment safety and efficacy of Boceprevir-based triple therapy in genotype 1 hepatitis C: the Australian multi-centre Boceprevir real world experience (SABRE-C)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 674A - 674A, presented at
, 2014, 'Understanding the Phases of Chronic Hepatitis B; the problem and a novel solution using renamed phases, the Hepatitis B Bear and a video (see " Understanding Hepatitis B " on YouTube)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1001A - 1002A, presented at
, 2014, 'The landscape of pregnant women with hepatitis B in a single center', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 77 - 77, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Understanding the phases of chronic hepatitis B: the problem and a novel solution using renamed phases, the hepatitis B bear and a video (see "Understanding Hepatitis B" on YouTube)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN A RENAL TRANSPLANT RECIPIENT SUCCESSFULLY TREATED WITH FECAL MICROBIOTA TRANSPLANTATION', in Nephrology, Melbourne Convention and Exhibition Centre Melbourne, Australia, presented at
, 2014, 'RENAL FUNCTION TESTING IN PATIENTS ON TENOFOVIR ANTIVIRAL THERAPY', in NEPHROLOGY, WILEY-BLACKWELL, pp. 72 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'UTILITY OF QUANTITATIVE HEPATITIS B E ANTIGEN AND SURFACE ANTIGEN IN THE PREDICTION OF HEPATITIS B E ANTIGEN SEROCONVERSION FOLLOWING PREGNANCY IN HBV', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, ENGLAND, London, pp. S295 - S295, presented at
, 2013, 'Efficacy and safety of tenofovir in pregnancy to prevent Mother to Baby transmission of HBV', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 625A - 625A, presented at
, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 641A - 642A, presented at
, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations', in Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.12212
, 2012, 'Lamivudine in pregnancy: Impact on Hepatitis B flares and HBeAg seroconversion post partum', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 355A - 355A, presented at
, 2012, 'The Hepatitis B Bear: Novel patient orientated information enhances patient understanding of the phases of Hepatitis B', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 355A - 355A, presented at
, 2011, 'NUCLEOT(S)IDE ANALOGUES TO PREVENT PERINATAL TRANSMISSION OF HBV: LAMIVUDINE IS EFFECTIVE BUT TENOFOVIR MAY BE BETTER', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 892A - 892A, presented at
, 2011, 'ULTRA DEEP PYROSEQUENCING IDENTIFIES MULTIDRUG RESISTANT HBV IN PREGNANT WOMEN UNDERGOING LAMIVUDINE THERAPY', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 1074A - 1075A, presented at
, 2011, 'LAMIVUDINE IN LATE PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: EFFECTIVENESS AND DETECTION OF ANTIVIRAL RESISTANCE', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S295 - S296, presented at
, 2009, 'QUANTITATIVE HBEAG AND HBSAG: LEVELS CORRELATE WITH HEPATITIS B VIRAL LOAD AND QUASI SPECIES SUGGESTING A SINGLE CONTROL MECHANISM', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 984A - 984A, presented at
, 2009, 'TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN CHRONIC HEPATITIS B INFECTION: REDUCE NUMBER OF BIOPSIES & SAVE MONEY', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 543A - 543A, presented at
, 2008, 'HEPATITIS C IN DIALYSIS AND RENAL TRANSPLANT PATIENTS - ANALYSIS OF THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY REVEALS SIGNIFICANT IMPACT OF HEPATITIS C INFECTION AFTER RENAL TRANSPLANTATION', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 1130A - 1130A, presented at
, 2008, 'PERINATAL TRANSMISSION OF HEPATITIS B VIRUS: VIRAL LOAD AND HBEAG STATUS ARE SIGNIFICANT RISK FACTORS', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 676A - 676A, presented at
, 2008, 'VIROLOGICAL HETEROGENEITY IN HEPATITIS B POSITIVE WOMEN; QUANTITATIVE HBeAg ESTIMATION DISTINGUISHES THOSE WITH SUBPOPULATIONS OF BASAL CORE PROMOTER MUTATIONS', in Journal of Hepatology, Elsevier Science BV, Amsterdam, Netherlands, pp. 365 - 366, presented at
, 2008, 'Correlates of HCV seronegative-immune status in high risk IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A356 - A356
, 2008, 'Is there still a role for lamivudine? Baseline HBeAg status and viral load at 6 and 12 months predicts long-term effectiveness of lamivudine in CHB patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A186 - A186, presented at
, 2008, 'Modeling population-based chronic hepatitis B screening and treatment to prevent cirrhosis and liver cancer among high risk populations in Australia', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A359
, 2008, 'Predictors of HCV incidence in IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A346 - A347
, 2003, 'Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infection', in Advances in Experimental Medicine and Biology, pp. 235 - 243
, 2000, 'Relating structure to function in the beta-propeller domain of dipeptidyl peptidase IV: Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity', in Advances in Experimental Medicine and Biology, pp. 89 - 95
Conference Posters
, 2022, 'Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?', Vol. 2022, http://dx.doi.org/10.1155/2022/3449938
Conference Presentations
, 2015, 'Efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus (vol 61, pg 502, 2014)'
Conference Abstracts
, 2020, 'Sustained virological response before hepatitis C-related hepatocellular carcinoma diagnosis is associated with improved survival', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 53 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'OVER THE SCOPE CLIPS FOR PRIMARY THERAPY OF BLEEDING UPPER GASTROINTESTINAL ULCERS: A RETROSPECTIVE CASE CONTROL STUDY', in GASTROINTESTINAL ENDOSCOPY, MOSBY-ELSEVIER, CA, San Diego, Vol. 89, pp. AB488 - AB489, presented at Digestive Disease Week (DDW), CA, San Diego, 18 May 2019 - 21 May 2019, http://dx.doi.org/10.1016/j.gie.2019.03.798
, 2018, 'FRAILTY AND AIMS65 SCORE PREDICT MORTALITY IN HOSPITALIZED PATIENTS WITH GASTROINTESTINAL BLEEDING: A PROSPECTIVE COHORT STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, Vol. 154, pp. S703 - S704, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011102599&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'PERINATAL TRANSMISSION HBV IN AWESTERN SETTING; WHAT IS THE MATERNAL VIRAL THRESHOLD AT WHICH ANTIVIRAL THERAPY SHOULD BE CONSIDERED?', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, Vol. 64, pp. S360 - S360, presented at EASL International Liver Congress, SPAIN, Barcelona, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)00532-8
, 2010, 'Vitamin D deficiency is common in patients with genotype 1 chronic hepatitis C and is associated with lower rate of SVR', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 25, pp. A132 - A132, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'Transient elastography (Fibroscan) in chronic hepatitis B infection: reduce number of biopsies & save money', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 24, pp. A308 - A308, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Preprints
, 2023, Temporal change in etiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients with hepatocellular carcinoma in New South Wales, Australia, http://dx.doi.org/10.1101/2023.02.20.23286164
, 2022, Lenvatinib for the treatment of hepatocellular carcinoma - a real-world multicentre Australian cohort study, http://dx.doi.org/10.21203/rs.3.rs-1714922/v1